Divalproex Sodium
Rank #154 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$103.4M
Total Cost
1,921,840
Total Claims
$103.4M
Total Cost
41,061
Prescribers
$54
Cost per Claim
167,976
Beneficiaries
2,244,145
30-Day Fills
$2,518
Avg Cost/Provider
47
Avg Claims/Provider
Share of Medicare Part D Spending
0.04%
of total Medicare Part D spending
$103.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $103.4M total
Top Prescribers of Divalproex Sodium
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Donald Vollmer | Family Practice | Hendersonville, TN | 4,723 | $116K |
| 2 | Michael Ahearn | Hospitalist | Kewanee, IL | 1,514 | $110K |
| 3 | Carole Rosanova | Neuropsychiatry | Kildeer, IL | 687 | $101K |
| 4 | Deborah Zielinski | Nurse Practitioner | Chicago, IL | 102 | $97K |
| 5 | Robert Morton | Psychiatry | Ada, OK | 861 | $95K |
| 6 | Hoover Royals | Family Practice | Dover, NC | 952 | $90K |
| 7 | Christopher Labonte | Internal Medicine | Town And Country, MO | 1,884 | $87K |
| 8 | Terence Frinks | Family Practice | Tucker, GA | 3,800 | $86K |
| 9 | Shephali Patel | Psychiatry | Chicago, IL | 4,085 | $82K |
| 10 | Festus Uzokwe | Psychiatry | Houston, TX | 899 | $80K |
| 11 | Ellie Mozingo | Psychiatry | Columbia, SC | 503 | $78K |
| 12 | John Weinstein | Psychiatry | Garden Grove, CA | 763 | $72K |
| 13 | Kay Lewis | Psychiatry | Houston, TX | 498 | $72K |
| 14 | Irving Restituyo | Internal Medicine | New Bedford, MA | 1,050 | $70K |
| 15 | Allan Mccorkle | Psychiatry | Lubbock, TX | 1,493 | $68K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 151 | Ipratropium/Albuterol Sulfate (Combivent Respimat) | $108.3M | 353,594 |
| 152 | Relugolix (Orgovyx) | $107.3M | 38,821 |
| 153 | Pen Needle, Diabetic (Ultra-Fine Mini Pen Needle) | $105.0M | 1,305,150 |
| 154 | Divalproex Sodium (Divalproex Sodium) | $103.4M | 1,921,840 |
| 155 | Nilotinib Hcl (Tasigna) | $100.9M | 6,308 |
| 156 | Quetiapine Fumarate (Quetiapine Fumarate) | $100.9M | 3,820,737 |
| 157 | Ubrogepant (Ubrelvy) | $100.6M | 75,781 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology